A Repeat Test for Liver Cirrhosis
Repeated measurements of the FIB-4 blood biomarker help predict cirrhosis risk
Luke Turner | | Quick Read
Fat accumulation in the liver can lead to cirrhosis or cancer. Symptoms of liver cirrhosis occur at a late stage when the chance of treatment is low – and, although blood tests can measure liver damage, cirrhosis risk prediction remains a challenge. New research has shown that repeated use of the fibrosis-4 index (FIB-4), a score that evaluates the degree of fibrosis, could better predict whether a patient will develop cirrhosis.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.